Keenova Therapeutics plc Contract Liability (Deferred Revenue)
Keenova Therapeutics plc had Contract Liability (Deferred Revenue) of $2.70 million as of 2020-12-25, per its 10-K filed 2021-03-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2021-03-10
- 2020-12-25: Contract with Customer, Liability, Current $2.70M.
- 2020-09-25: Contract with Customer, Liability, Current $3.00M.
- 2020-06-26: Contract with Customer, Liability, Current $3.40M.
- 2020-03-27: Contract with Customer, Liability, Current $4.70M.
| Period end | Contract with Customer, Liability, Current | Contract with Customer, Liability, Current as first filed |
|---|---|---|
| 2020-12-25 | $2.70M 10-K · filed 2021-03-10 | |
| 2020-09-25 | $3.00M 10-Q · filed 2020-11-03 | |
| 2020-06-26 | $3.40M 10-Q · filed 2020-08-04 | |
| 2020-03-27 | $4.70M 10-Q · filed 2020-05-06 | |
| 2019-12-27 | $5.60M 10-K · filed 2021-03-10 | |
| 2019-09-27 | $5.90M 10-Q · filed 2019-11-05 | |
| 2019-06-28 | $20.30M 10-Q · filed 2019-08-06 | |
| 2019-03-29 | $20.00M 10-Q · filed 2019-05-07 | |
| 2018-12-28 | $20.40M 10-K · filed 2020-02-26 | |
| 2018-09-28 | $21.20M 10-Q · filed 2018-11-06 | |
| 2018-06-29 | $20.20M 10-Q · filed 2018-08-07 | |
| 2018-03-30 | $13.10M 10-Q · filed 2018-05-08 | |
| 2017-12-29 | $14.00M 10-K · filed 2019-02-26 | $13.90M 10-Q · filed 2018-05-08 |